North America Endoluminal Suturing Devices Market Size, Share & Industry Trends Analysis Report By Application (Gastrointestinal Surgery, Bariatric Surgery, Gastroesophageal Reflux Disease Surgery and Others), By End User, By Country and Growth Forecast, 2022 - 2028

The North America Endoluminal Suturing Devices Market is expected to witness market growth of 11.4% CAGR during the forecast period (2022-2028).

Endoluminal suturing devices provide a higher rate of recovery and meet consumer demand for noninvasive medical procedures, which improves patient experience and results in quicker recovery times, fewer hospital visits, and shorter hospital stays. The acceptability of endoluminal suturing devices has also been aided by the use of sophisticated tools. The primary drivers propelling the growth of the endoluminal suturing devices market are the increasing prevalence of obesity and chronic diseases that create patient pools, as well as the rising demand for less invasive operations.

Obesity has become a pandemic, a serious health risk, and the second-most preventable cause of death in the United States. Endoluminal surgery meets the need of patients for minimally invasive procedures that are carried out in a hollow organ employing suturing and stapling surgical techniques.

Endoluminal surgeries are becoming more popular as people become more aware of the advantages of minimally invasive techniques and the drop in post-operative problems. These elements might help to explain why the market for endoluminal suturing devices is expanding. Increase in the number of suturing procedures, the aging population, and technological advancements in the production of suturing devices.

Since non-emergency treatments have been severely curtailed or postponed due to coronavirus disease 2019 (COVID-19) for almost two months now, doctors and health care authorities are concerned about Canada's rising backlog of urgent surgery. The World Health Organization estimates that between 20 and 50 million people experienced treatable injuries in February 2020, including bone fractures, and underwent successful ankle arthroplasty and other bone procedures.

The US market dominated the North America Endoluminal Suturing Devices Market by Country in 2021; thereby, achieving a market value of $42.9 million by 2028. The Canada market is estimated to grow at a CAGR of 13.9% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 12.9% during (2022 - 2028).

Based on Application, the market is segmented into Gastrointestinal Surgery, Bariatric Surgery, Gastroesophageal Reflux Disease Surgery and Others. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apollo Endosurgery, Inc., Johnson & Johnson, Medtronic PLC, Cook Medical, Inc. (Cook Group), USGI Medical, Ovesco Endoscopy AG, Endo Tools Therapeutics S.A., ErgoSuture, Suture Ltd.

Scope of the Study

Market Segments Covered in the Report:

By Application

• Gastrointestinal Surgery
• Bariatric Surgery
• Gastroesophageal Reflux Disease Surgery
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Apollo Endosurgery, Inc.
• Johnson & Johnson
• Medtronic PLC
• Cook Medical, Inc. (Cook Group)
• USGI Medical
• Ovesco Endoscopy AG
• Endo Tools Therapeutics S.A.
• ErgoSuture
• Suture Ltd.

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free